Gastric Cancer

被引：13

作者：

不详

机构：

来源：

CURRENT PROBLEMS IN CANCER | 2011年 / 35卷 / 03期

关键词：

PHASE-II TRIAL; RANDOMIZED CLINICAL-TRIAL; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; COMPARING ADJUVANT FLUOROURACIL; LYMPH-NODE DISSECTION; MESSENGER-RNA LEVELS; SUBTOTAL GASTRECTOMY; MITOMYCIN-C; PERITONEAL RECURRENCE;

D O I：

10.1016/j.currproblcancer.2011.03.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：97 / 127

页数：31

相关论文

共 152 条

[81] FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL OF ADJUVANT CHEMOTHERAPY WITH THE MODIFIED FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN REGIMEN IN RESECTABLE GASTRIC-CANCER [J].

LISE, M ;

NITTI, D ;

MARCHET, A ;

SAHMOUD, T ;

BUYSE, M ;

DUEZ, N ;

FIORENTINO, M ;

DOSSANTOS, JG ;

LABIANCA, R ;

ROUGIER, P ;

GIGNOUX, M .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) :2757-2763

[82] Optimization of dose distributions for adjuvant loco-regional radiotherapy of gastric cancer by IMRT [J].

Lohr, F ;

Dobler, B ;

Mai, S ;

Hermann, B ;

Tiefenbacher, U ;

Wieland, P ;

Steil, V ;

Wenz, F .

STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (08) :557-563

[83]

Lordick F, 2007, J CLIN ONCOL, V25

[84] Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer [J].

Lordick, F ;

Lorenzen, S ;

Stollfuss, J ;

Vehling-Kaiser, U ;

Kullmann, F ;

Hentrich, M ;

Zumschlinge, R ;

Dietzfelbinger, H ;

Thoedtmann, J ;

Hennig, M ;

Seroneit, T ;

Bredenkamp, R ;

Duyster, J ;

Peschel, C .

BRITISH JOURNAL OF CANCER, 2005, 93 (02) :190-194

[85]

Lowy AM, 2001, ANN SURG ONCOL, V8, P519, DOI 10.1245/aso.2001.8.6.519

[86] Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal Adenocarcinoma [J].

Lustberg, Maryam B. ;

Bekaii-Saab, Tanios ;

Young, Donn ;

Otterson, Gregory ;

Burak, William ;

Abbas, Abbas ;

McCracken-Bussa, Barbara ;

Lustberg, Mark E. ;

Villalona-Calero, Miguel A. .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) :713-718

[87] Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. [J].

Macdonald, JS ;

Smalley, SR ;

Benedetti, J ;

Hundahl, SA ;

Estes, NC ;

Stemmermann, GN ;

Haller, DG ;

Ajani, JA ;

Gunderson, LL ;

Jessup, JM ;

Martenson, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) :725-730

[88] ADJUVANT TREATMENT OF GASTRIC-CANCER [J].

MACDONALD, JS ;

SCHNALL, SF .

WORLD JOURNAL OF SURGERY, 1995, 19 (02) :221-225

[89] New Metastatic Lymph Node Ratio System Reduces Stage Migration in Patients Undergoing D1 Lymphadenectomy for Gastric Adenocarcinoma [J].

Maduekwe, Ugwuji N. ;

Lauwers, Gregory Y. ;

Fernandez-del-Castillo, Carlos ;

Berger, David L. ;

Ferguson, Charles M. ;

Rattner, David W. ;

Yoon, Sam S. .

ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) :1267-1277

[90] ADJUVANT CHEMOTHERAPY ENHANCES LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED GASTRIC-CANCER FOLLOWING CURATIVE RESECTION [J].

MAEHARA, Y ;

MORIGUCHI, S ;

SAKAGUCHI, Y ;

EMI, Y ;

KOHNOE, S ;

TSUJITANI, S ;

SUGIMACHI, K .

JOURNAL OF SURGICAL ONCOLOGY, 1990, 45 (03) :169-172

← 4 5 6 7 8 9 10 11 12 13 →